{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:54:55Z","timestamp":1778954095231,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T00:00:00Z","timestamp":1666483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T00:00:00Z","timestamp":1666483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s13760-022-02124-7","type":"journal-article","created":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T15:02:37Z","timestamp":1666537357000},"page":"2139-2146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-contactin-associated protein-like 2 antibody autoimmune encephalitis with rapidly progressive parkinsonism: a case report and literature review"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6100-1088","authenticated-orcid":false,"given":"Xiaohong","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunsen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,23]]},"reference":[{"issue":"2","key":"2124_CR1","first-page":"91","volume":"50","author":"Anonymous.","year":"2017","unstructured":"Anonymous. (2017) Expert consensus on the diagnosis and treatment of autoimmune encephalitis in China. Chin J Neurol 50(2):91\u201398","journal-title":"Chin J Neurol"},{"issue":"5","key":"2124_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/ane.13291","volume":"142","author":"G Nepal","year":"2020","unstructured":"Nepal G, Shing YK, Yadav JK, Rehrig JH, Ojha R, Huang DY, Gajurel BP (2020) Efficacy and safety of rituximab in autoimmune encephalitis: a meta-analysis. Acta Neurol Scand 142(5):449\u2013459. https:\/\/doi.org\/10.1111\/ane.13291","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"2124_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.24200","volume":"76","author":"SR Irani","year":"2014","unstructured":"Irani SR, Gelfand JM, Al-Diwani A, Vincent A (2014) Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol 76(2):168\u2013184. https:\/\/doi.org\/10.1002\/ana.24200","journal-title":"Ann Neurol"},{"key":"2124_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mcn.2015.11.012","volume":"70","author":"A Gordon","year":"2016","unstructured":"Gordon A, Salomon D, Barak N, Pen Y, Tsoory M, Kimchi T, Peles E (2016) Expression of Cntnap2 (Caspr2) in multiple levels of sensory systems. Mol Cell Neurosci 70:42\u201353. https:\/\/doi.org\/10.1016\/j.mcn.2015.11.012","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"2124_CR5","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/ejn.14081","volume":"48","author":"M Saint-Martin","year":"2018","unstructured":"Saint-Martin M, Joubert B, Pellier-Monnin V, Pascual O, Noraz N, Honnorat J (2018) Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases. Eur J Neurosci 48(3):1906\u20131923. https:\/\/doi.org\/10.1111\/ejn.14081","journal-title":"Eur J Neurosci"},{"issue":"10","key":"2124_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1793","volume":"10","author":"P Ghimire","year":"2020","unstructured":"Ghimire P, Khanal UP, Gajurel BP, Karn R, Rajbhandari R, Paudel S, Gautam N, Ojha R (2020) Anti-LGI1, anti-GABABR, and anti-CASPR2 encephalitides in Asia: a systematic review. Brain Behav 10(10):e01793. https:\/\/doi.org\/10.1002\/brb3.1793","journal-title":"Brain Behav"},{"issue":"12","key":"2124_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"3","key":"2124_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10072-017-3222-0","volume":"39","author":"S Kannoth","year":"2018","unstructured":"Kannoth S, Nambiar V, Gopinath S, Anandakuttan A, Mathai A, Rajan PK (2018) Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 39(3):455\u2013460. https:\/\/doi.org\/10.1007\/s10072-017-3222-0","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"9","key":"2124_CR9","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain J Neurol 133(9):2734\u20132748. https:\/\/doi.org\/10.1093\/brain\/awq213","journal-title":"Brain J Neurol"},{"issue":"9","key":"2124_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","volume":"73","author":"B Joubert","year":"2016","unstructured":"Joubert B, Saint-Martin M, Noraz N, Picard G, Rogemond V, Ducray F, Desestret V, Psimaras D, Delattre JY, Antoine JC, Honnorat J (2016) Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and Seizures. JAMA Neurol 73(9):1115\u20131124. https:\/\/doi.org\/10.1001\/jamaneurol.2016.1585","journal-title":"JAMA Neurol"},{"issue":"4","key":"2124_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, H\u00f6ftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Pr\u00fcss H, Rae-Grant A, Reindl M, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15(4):391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"2124_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3389\/fimmu.2018.00703","volume":"9","author":"CG Bien","year":"2018","unstructured":"Bien CG (2018) Overinterpretation and overtreatment of low-titer antibodies against contactin-associated protein-2. Front Immunol 9:703. https:\/\/doi.org\/10.3389\/fimmu.2018.00703","journal-title":"Front Immunol"},{"issue":"3","key":"2124_CR13","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1212\/CPJ.0000000000000978","volume":"11","author":"PS Swayang","year":"2021","unstructured":"Swayang PS, Nalini A, Preethish-Kumar V, Udupa K, Yadav R, Vengalil S, Reshma SS, Polavarapu K, Nashi S, Sathyaprabha TN, Treesa Thomas P, Maya B, Jamuna R, Mahadevan A, Netravathi M (2021) CASPR2-related morvan syndrome: autonomic, polysomnographic, and neuropsychological observations. Neurol Clin Pract 11(3):e267\u2013e276. https:\/\/doi.org\/10.1212\/CPJ.0000000000000978","journal-title":"Neurol Clin Pract"},{"issue":"5","key":"2124_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","volume":"13","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13(5):290\u2013301. https:\/\/doi.org\/10.1038\/nrneurol.2017.43","journal-title":"Nat Rev Neurol"},{"issue":"20","key":"2124_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","volume":"70","author":"KM Tan","year":"2008","unstructured":"Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ (2008) Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 70(20):1883\u20131890. https:\/\/doi.org\/10.1212\/01.wnl.0000312275.04260.a0","journal-title":"Neurology"},{"issue":"5","key":"2124_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"2124_CR17","first-page":"249","volume":"88","author":"AJ Jagadeesan","year":"2017","unstructured":"Jagadeesan AJ, Murugesan R, Vimala Devi S, Meera M, Madhumala G, Vishwanathan Padmaja M, Ramesh A, Banerjee A, Sushmitha S, Khokhlov AN, Marotta F, Pathak S (2017) Current trends in etiology, prognosis and therapeutic aspects of Parkinson\u2019s disease a review. Acta Bio Med Atenei Parmen 88:249\u2013262","journal-title":"Acta Bio Med Atenei Parmen"},{"issue":"1","key":"2124_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/1531-8257(199901)14:1<10::aid-mds1005>3.0.co;2-4","volume":"14","author":"JM Graham","year":"1999","unstructured":"Graham JM, Sagar HJ (1999) A data-driven approach to the study of heterogeneity in idiopathic Parkinson\u2019s disease: identification of three distinct subtypes. Mov Disord Off J Mov Disord Soc 14(1):10\u201320. https:\/\/doi.org\/10.1002\/1531-8257(199901)14:1%3c10::aid-mds1005%3e3.0.co;2-4","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"10","key":"2124_CR19","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D (2018) Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 33(10):1601\u20131608. https:\/\/doi.org\/10.1002\/mds.27362","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"4","key":"2124_CR20","first-page":"315","volume":"12","author":"SE Taycan","year":"2011","unstructured":"Taycan SE, Demir S, Cedil;Elikel, F. C, (2011) The relationship of selective serotonin reuptake inhibitors with parkinson\u2019s disease and parkinsonism: two case reports. Anadolu Psikiyatri Dergisi 12(4):315\u2013317","journal-title":"Anadolu Psikiyatri Dergisi"},{"issue":"7","key":"2124_CR21","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.pnpbp.2006.03.002","volume":"30","author":"E Ozalp","year":"2006","unstructured":"Ozalp E, Soygur H, Cankurtaran ES, Turhan L, Cekic T, Akarsu ES, Palaoglu O, Ayhan IH (2006) Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report. Progress Neuro-psychopharmacol Biolo Psychiatry 30(7):1337\u20131339. https:\/\/doi.org\/10.1016\/j.pnpbp.2006.03.002","journal-title":"Progress Neuro-psychopharmacol Biolo Psychiatry"},{"issue":"1","key":"2124_CR22","doi-asserted-by":"publisher","first-page":"126.e1","DOI":"10.1016\/j.genhosppsych.2013.09.010","volume":"36","author":"S Ak","year":"2014","unstructured":"Ak S, An\u0131lYa\u011fc\u0131o\u011flu AE (2014) Escitalopram-induced Parkinsonism. Gen Hosp Psychiatry 36(1):126.e1-126.e1262. https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.09.010","journal-title":"Gen Hosp Psychiatry"},{"issue":"2 Pt 1","key":"2124_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.lpm.2016.11.008","volume":"46","author":"C Tranchant","year":"2017","unstructured":"Tranchant C (2017) Autres syndromes parkinsoniens [Other causes of parkinsonism]. Presse Med (Paris, France\u202f: 1983) 46(2 Pt 1):210\u2013217. https:\/\/doi.org\/10.1016\/j.lpm.2016.11.008","journal-title":"Presse Med (Paris, France : 1983)"},{"key":"2124_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jns.2016.01.006","volume":"362","author":"S Kannoth","year":"2016","unstructured":"Kannoth S, Anandakkuttan A, Mathai A, Sasikumar AN, Nambiar V (2016) Autoimmune atypical parkinsonism - A group of treatable parkinsonism. J Neurol Sci 362:40\u201346. https:\/\/doi.org\/10.1016\/j.jns.2016.01.006","journal-title":"J Neurol Sci"},{"issue":"Pt 8","key":"2124_CR25","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/brain\/awh203","volume":"127","author":"J Dalmau","year":"2004","unstructured":"Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B, Saiz A, Meneses P, Rosenfeld MR (2004) Clinical analysis of anti-Ma2-associated encephalitis. Brain J Neurol 127(Pt 8):1831\u20131844. https:\/\/doi.org\/10.1093\/brain\/awh203","journal-title":"Brain J Neurol"},{"issue":"5","key":"2124_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Ari\u00f1o H, Petit-Pedrol M, Leypoldt F, K\u00f6rtv\u00e9lyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MW, SillevisSmitt PA, Graus F, Dalmau J, Titulaer MJ (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87(5):521\u2013528. https:\/\/doi.org\/10.1212\/WNL.0000000000002917","journal-title":"Neurology"},{"issue":"10","key":"2124_CR27","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.parkreldis.2015.08.014","volume":"21","author":"MM Kurtis","year":"2015","unstructured":"Kurtis MM, Toledano R, Garc\u00eda-Morales I, Gil-Nagel A (2015) Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis. Parkinsonism Relat Disord 21(10):1286\u20131287. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.014","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-02124-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-022-02124-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-02124-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T02:12:11Z","timestamp":1701137531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-022-02124-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,23]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2124"],"URL":"https:\/\/doi.org\/10.1007\/s13760-022-02124-7","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,23]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the Ethics Committee of Sichuan Provincial People\u2019s Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient has consented to the submission of the case report to the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}